Provided By GlobeNewswire
Last update: Sep 3, 2025
SEATTLE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that its Board of Directors has appointed Maya Martinez-Davis as an independent director to the Company’s Board of Directors, effective today.
Read more at globenewswire.com4.84
+0.01 (+0.21%)
Find more stocks in the Stock Screener